Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03865420 · ClinicalTrials.gov registry record

Amyotrophic Lateral Sclerosis (ALS) Families Project

A clinical trial of ALS, sponsored by Columbia University.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT03865420 is a study of ALS that is actively recruiting participants, run by Columbia University. The registered enrollment target is 300 participants, below the 1,021-participant average among 19 other ALS trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03865420, a study of ALS, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron degeneration begins and how or why it progresses. This study provides genetic counseling and testing to help participants understand and manage their risk and determine if they want to learn their genetic status. This study will follow unaffected ALS gene mutation carriers on an annual basis to gather essential information that will ultimately help researchers develop novel therapies for the prevention and treatment of ALS.

Conditions Studied

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2018-09-11
Est. Completion 2027-01

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03865420

The ClinicalTrials.gov registry entry for NCT03865420 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,021-participant average among 19 other ALS trials with a reported enrollment target (71% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ALS appearing as the primary indexed condition, and to 0 interventions.

NCT03865420 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03865420 about?

NCT03865420 is a clinical study titled "Amyotrophic Lateral Sclerosis (ALS) Families Project". This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron degeneration begins and how or why it progresses. This study provides genetic counseling and testing to help participants understand and man...

What is the current status of trial NCT03865420?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2018-09-11. Estimated completion is 2027-01.

What conditions does trial NCT03865420 study?

This clinical trial studies the following conditions: ALS.

Who is sponsoring clinical trial NCT03865420?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03865420 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ALS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.